Skip to main content
SpringerLink
Log in

Nebenwirkungen von Clonidin

  • Chapter
Zentrale Blutdruckregulation durch α 2-Rezeptorenstimulation

Zusammenfassung

Die Qualität antihypertensiver Substanzen, die häufig jahrelang verabreicht werden, ist neben ihrer antihypertensiven Potenz in besonders hohem Maße von der Anzahl und Intensität ihrer Nebenwirkungen abhängig.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Heimsoth V, Bock KD: Ergebnisse der Notfall- und Langzeitbehandlung mit 2-(2,6-Dichlorphenylamino)-2-imidazolin. In: Hoehdrucktherapie. Hrsg: L Heilmeyer, HJ Holtmeier und EF Pfeiffer. Stuttgart: Thieme 1968, S. 137.

    Google Scholar 

  2. Mroczek WJ, Davidoval M, Finnerty FA: Prolonged treatment with Clonidine: comparative antihypertensive effects alone and with a diuretic agent. Amer J Cardiol 30:536 (1972).

    Article  PubMed  CAS  Google Scholar 

  3. Conolly ME, Briant RH, George CF, Dollery CT: A crossover comparison of Clonidine and methyldopa in hypertension. Europ J clin Pharmacol 4:222–227 (1972).

    Article  Google Scholar 

  4. Ng J, Phelan EL, McGregor DD, Laverty R, Taylor KM, Smirk Sir FH: Properties of cata-pres, a new hypotensive drug. A preliminary report. NZ med J 66:864 (1967).

    CAS  Google Scholar 

  5. Becker-Christensen F, Bang HO, Ditzel J: Treatment of severe hypertension with catapres. Acta med scand vol 190:21–26 (1971).

    Article  PubMed  CAS  Google Scholar 

  6. Conner CS, Watanabe AS: Clonidine overdose: A review. Amer J Hosp Pharm 36:906–911 (1979).

    CAS  Google Scholar 

  7. Lehmann A: Vergiftungsfâlle mit Clonidin. Schweiz Rundsch Med (Praxis) 70:1497–1500 (1981).

    CAS  Google Scholar 

  8. Rotellar JAO, Monasterio ES, De La Cruz JS, Gene CG: Clonidine in thousand-fold overdose. The Lancet, June 13 (1981).

    Google Scholar 

  9. Schwarz D, Michel D, Strian F: Depressive Reaktionen unter antihypertensiver Behandlung. Arch Psychiat Nervenkr 218:41–50 (1973).

    Article  PubMed  CAS  Google Scholar 

  10. Safar M, Sobel A, Milliez P: Antihypertensive effect of Clonidine and salt depletion in severe hypertension: Clinical and haemodynamic study. Europ J clin Pharmacol 5:203–209 (1973).

    Article  CAS  Google Scholar 

  11. Chrysant SG, Dillard BL, Smith JW, Manion Cval: Antihypertensive effectiveness of Clonidine and chlorthalidone as step 1 drugs. Cur Ther Res 30:943 (1981).

    Google Scholar 

  12. Trial MRC: Medical research council working party on mild to moderate Hypertension: Adverse reactions to Bendrofluazide and Propranolol for the treatment of mild hypertension. Lancet 8246:539 (1981).

    Google Scholar 

  13. Davidoval M, Kakaviatos N, Finnerty FA, Jr: The antihypertensive effects of an imidazoline compound (Catapres). A preliminary clinical and hemodynamic evaluation in man. Clin Pharmacol Ther 8:810 (1967).

    Google Scholar 

  14. Koch M: Natrium- und Wasserhaushalt bei spontan-hypertensiven Ratten unter Clonidin. Clonidin-Workshop 1982 (ed: Bock KD, Hayduck K) im Druck.

    Google Scholar 

  15. Campese VM, Romoff M, Telfer N, Weidmann P, Massry SG: Role of sympathetic nerve inhibition and body sodium-volume state in the antihypertensive action of Clonidine in essential hypertension. Kidney Int 18:351–357 (1980).

    Article  PubMed  CAS  Google Scholar 

  16. Yeh BK, Nantel A, Goldberg LI: Antihypertensive effect of Clonidine. Arch Intern Med 127:233–237(1971).

    Article  PubMed  CAS  Google Scholar 

  17. Thormann J, Neuss H, Horn H, Schlepper M: Clonidin-induzierte Bradykardie. Dtsch med Wschr 106:141–145 (1981).

    Article  PubMed  CAS  Google Scholar 

  18. Keränen A, Nykänen S, Taskinen J: Pharmacokinetics and side-effects of Clonidine. Europ J clin Pharmacol 13:97–101 (1978).

    Article  Google Scholar 

  19. Anavekar SN, Jarrott B, Toscano M, Louis WJ: Pharmacokinetic and pharmacodynamic studies of oral Clonidine in normotensive subjects. Eur J Clin Pharmacol 23:1–5 (1982).

    Article  PubMed  CAS  Google Scholar 

  20. Frisk-Holmberg M: Effect concentration relationships of Clonidine in essential hypertension. Clonidin-Workshop 1982 (ed: Bock KD, Hayduck K) im Druck.

    Google Scholar 

  21. Kirch W, Distler A: Cross-over-Doppelblindstudie über die antihypertensive Wirkung von N-Amidino-2-(2,6-Dichlorphenyl)Acetamid-Hydrochlorid und Clonidin. Verh dtsch Ges inn Med 83:318 (1977).

    PubMed  CAS  Google Scholar 

  22. Reid JL, Dargie HJ, Davies DS, Wing LMH, Hamilton CA, Dollery CT: Clonidine withdrawal in hypertension. Lancet 1:1171 (1977).

    Article  PubMed  CAS  Google Scholar 

  23. Hoobler SW, Kashima T: Central nervalous system actions of Clonidine in hypertension. Mayo Clin Proc 52:395 (1977).

    PubMed  CAS  Google Scholar 

  24. Anderson RJ, Ram CvalS, Kaplan NM: Abrupt discontinuation of Clonidine therapy: Monitoring the blood pressure changes in outpatients with a semiautomatic blood pressure recording device. Clin Res 27:311A (1979).

    Google Scholar 

  25. Geyskes GG, Boer P, Dorhout Mees EJ: Clonidine withdrawal. Mechanism and frequency of rebound hypertension. Br J Clin Pharmacol 7:55 (1979).

    PubMed  CAS  Google Scholar 

  26. Whitsett TL: Abrupt cessation of Clonidine administration: A prospective study. Am J Cardiol 41:1285(1978).

    Article  PubMed  CAS  Google Scholar 

  27. Planz G, Beckenbauer U, Bundschu HD: Response of plasma catecholamines and blood pressure to Clonidine and to sudden withdrawal of the drug in subjects with essential hypertension. Int J clin Pharmacol 20:474 (1982).

    CAS  Google Scholar 

  28. Weber MA: Discontinuation syndrome following cessation of treatment with Clonidine and other antihypertensive agents. J Cardiovasc Pharmacol 2: Suppl. 1, 73 (1980).

    Article  Google Scholar 

  29. Burden AC, Alexander CPT: Rebound hypertension after acute methyldopa withdrawal. Br Med J 1:1056(1976).

    Article  PubMed  CAS  Google Scholar 

  30. Scott JN, McDevitt DG: Rebound hypertension after acute methyldopa withdrawal. Br Med J 2:367(1976).

    Google Scholar 

  31. Kristensen BO, Steiness E, Weeks J: Propranolol withdrawal and thyroid hormones in patients with essential hypertension. Clin Pharmacol Ther 23:624 (1978).

    PubMed  CAS  Google Scholar 

  32. Miller RR, Olson HG, Amsterdam EA, Mason DT: Propranolol withdrawal rebound phenomenon. N Engl J Med 293:416 (1975).

    Article  PubMed  CAS  Google Scholar 

  33. Packer M, Meller J, Medina N, Gorlin R, Hermann Mval: Rebound hemodynamic events after the abrupt withdrawal of nitroprusside in patients with severe chronic heart failure. N Engl J Med 301:1193 (1979).

    Article  PubMed  CAS  Google Scholar 

  34. Keim HJ, Drayer JIM, Case DB, Lopez-Ovejero J, Wallace JM, Weber MA, Laragh JH: A role for renin in rebound hypertension and encephalopathy after infusion of saralasin acetate. N Engl J Med 295:1175 (1976).

    Article  PubMed  CAS  Google Scholar 

  35. Thoolen MJMC, Timmermann PBMWM, van Zwieten PA: The Clonidine withdrawal syndrome, its reproduction and evaluation in laboratory animal models. Gen Pharmac 12:303 (1981).

    Article  CAS  Google Scholar 

  36. Rebound Hypertension. The Catapres Record. Ed by Boehringer Ingelheim, 1976.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinische Klinik, Klinikum Steglitz der FU Berlin, Hindenburgdamm 30, 1000, Berlin 45, Deutschland

    Prof. Dr. Th. Philipp

Authors
  1. Prof. Dr. Th. Philipp
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Innere Abteilung, Marien-Hospital, Rochusstraße 2, 4000, Düsseldorf, Deutschland

    K. Hayduk

  2. Medizinische Klinik und Poliklinik, Universitätsklinikum Essen, Hufelandstraße 55, 4300, Essen 1, Deutschland

    K. D. Bock

Rights and permissions

Reprints and permissions

Copyright information

© 1983 Dr. Dietrich Steinkopff Verlag, GmbH & Co. KG, Darmstadt

About this chapter

Cite this chapter

Philipp, T. (1983). Nebenwirkungen von Clonidin. In: Hayduk, K., Bock, K.D. (eds) Zentrale Blutdruckregulation durch α 2-Rezeptorenstimulation. Steinkopff. https://doi.org/10.1007/978-3-642-48440-7_23

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-48440-7_23

  • Publisher Name: Steinkopff

  • Print ISBN: 978-3-7985-0624-4

  • Online ISBN: 978-3-642-48440-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation